This is an active, unpublished trial registration examining an exploratory combination strategy (allopurinol plus sertraline) for depression; no results are reported and the design is early-phase Phase 2/3.
Reported
Planned enrollment70
Primary outcome measureChange in 17-item Ham-D depression score at…
PhasePhase 2, Phase 3